Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (131-140 of 336) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 25, 2006
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancerGershon Y Locker, Stanley Hamilton, Jules Harris, et al.
Lancet (London, England)|June 18, 2013
Tamoxifen therapy for patients with breast cancerPatrick Neven, Heikki Joensuu, Heikki Joenssu, et al.
Lab on a Chip|July 28, 2021
Inertial focusing of circulating tumor cells in whole blood at high flow rates using the microfluidic CTCKey™ device for CTC enrichmentKaylee Judith Smith, Jessica Antoinette Jana, Anna Kaehr, et al.
Journal of the National Cancer Institute|March 8, 2012
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patientsJames M Rae, Suzy Drury, Daniel F Hayes, et al.
Brain Imaging and Behavior|January 27, 2016
Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysisMi Sook Jung, Min Zhang, Mary K Askren, et al.
Clinical Biochemistry|May 1, 2016
Comparative analysis of circulating tumor DNA stability In K<sub>3</sub>EDTA, Streck, and CellSave blood collection tubesQing Kang, N Lynn Henry, Costanza Paoletti, et al.
Breast Cancer Research and Treatment|August 21, 2014
Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigationMary K Askren, Misook Jung, Marc G Berman, et al.
Breast Cancer Research and Treatment|June 28, 2018
Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathyYihan Sun, Jae Hyun Kim, Kiran Vangipuram, et al.
Breast Cancer Research and Treatment|February 19, 2020
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancerThomas L Gonzalez, Molly Hancock, Siqi Sun, et al.
Breast Cancer Research and Treatment|March 18, 2020
Correction to: Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancerThomas L Gonzalez, Molly Hancock, Siqi Sun, et al.
Pageof 34

Showing results (131-140 of 336) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 25, 2006
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancerGershon Y Locker, Stanley Hamilton, Jules Harris, et al.
Lancet (London, England)|June 18, 2013
Tamoxifen therapy for patients with breast cancerPatrick Neven, Heikki Joensuu, Heikki Joenssu, et al.
Lab on a Chip|July 28, 2021
Inertial focusing of circulating tumor cells in whole blood at high flow rates using the microfluidic CTCKey™ device for CTC enrichmentKaylee Judith Smith, Jessica Antoinette Jana, Anna Kaehr, et al.
Journal of the National Cancer Institute|March 8, 2012
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patientsJames M Rae, Suzy Drury, Daniel F Hayes, et al.
Brain Imaging and Behavior|January 27, 2016
Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysisMi Sook Jung, Min Zhang, Mary K Askren, et al.
Clinical Biochemistry|May 1, 2016
Comparative analysis of circulating tumor DNA stability In K<sub>3</sub>EDTA, Streck, and CellSave blood collection tubesQing Kang, N Lynn Henry, Costanza Paoletti, et al.
Breast Cancer Research and Treatment|August 21, 2014
Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigationMary K Askren, Misook Jung, Marc G Berman, et al.
Breast Cancer Research and Treatment|June 28, 2018
Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathyYihan Sun, Jae Hyun Kim, Kiran Vangipuram, et al.
Breast Cancer Research and Treatment|February 19, 2020
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancerThomas L Gonzalez, Molly Hancock, Siqi Sun, et al.
Breast Cancer Research and Treatment|March 18, 2020
Correction to: Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancerThomas L Gonzalez, Molly Hancock, Siqi Sun, et al.
Pageof 34